Source:http://linkedlifedata.com/resource/pubmed/id/15706467
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2005-2-11
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0176-3679
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
38
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
39-40
|
| pubmed:meshHeading |
pubmed-meshheading:15706467-Adult,
pubmed-meshheading:15706467-Antipsychotic Agents,
pubmed-meshheading:15706467-Clozapine,
pubmed-meshheading:15706467-Drug Synergism,
pubmed-meshheading:15706467-Drug Therapy, Combination,
pubmed-meshheading:15706467-Humans,
pubmed-meshheading:15706467-Schizophrenia,
pubmed-meshheading:15706467-Schizophrenic Psychology,
pubmed-meshheading:15706467-Sulpiride
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
|
| pubmed:publicationType |
Letter
|